Gonorrhea is a very common infectious disease. It is transmitted through sexual contact with the penis, vagina, mouth, or anus of an infected partner. Gonorrhea can also be spread perinatally from mother to baby during childbirth.
Untreated gonorrhea can cause serious and permanent health problems in both women and men.
Gonorrhea has progressively developed resistance to the antibiotics drugs prescribed to treat it, thus complicating the ability of providers to treat the disease successfully. For this reason, it is crucial to continually monitor antibiotic resistance as well as research and develop new treatment regimens.
CERID is working to combat Neisseria resistance by developing novel drug leads through a structural-based drug design pipeline in collaboration with the Seattle Structural Genomics Center for Infectious Disease (SSGCID).